Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma × Luteolin × 90 days × Clear all

Sponsor

Interventions

pembrolizumab 17 Magnetic Resonance Spectroscopy 14 Specimen Handling 13 Cisplatin 13 Carboplatin 10 Paclitaxel 9 Platinum 7 1,2-diaminocyclohexaneplatinum II citrate 7 Cetuximab 6 Radiotherapy, Intensity-Modulated 5 Radiotherapy 5 Pemetrexed 5 Biopsy 5 osimertinib 4 durvalumab 4 cemiplimab 4 Radiation 4 1-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine 4 (225)Ac-DOTA-c(RGDyK) 4 Taxes 3 Nivolumab 3 Cyclophosphamide 3 olaparib 2 ipatasertib 2 fludarabine phosphate 2 fludarabine 2 cabozantinib 2 Tadalafil 2 Oxaliplatin 2 Ipilimumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡